Zimmer Biomet Holdings, Inc (NYSE:ZBH) reported fourth-quarter adjusted EPS of $2.31, up from $2.20 a year ago, beating the ...

With the $1.1 billion acquisition, Zimmer Biomet expects its sports medicine, extremities and trauma segment will outpace ...

CEO Ivan Tornos highlighted that Zimmer Biomet achieved nearly 5% constant currency sales growth in Q4 2024, marking the 12th consecutive quarter of mid-single-digit or better growth. The performance ...

Through the $1.1 billion acquisition, Zimmer Biomet expects its sports medicine, extremities and trauma segment to outpace hips and knees, moving forward, according to a Feb. 6 report from Medtech ...

Rowley Law PLLC is investigating potential securities law violations by Paragon 28, Inc. (NYSE: FNA) and its board ...

NEW YORK, Jan. 31, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Paragon 28 ... of the company by Zimmer Biomet Holdings, Inc. (NYSE: ZBH).

Q4 2024 Earnings Call Transcript February 6, 2025 Zimmer Biomet Holdings, Inc. beats earnings expectations. Reported EPS is ...

Zimmer Biomet shares at $105 reveal value at 13 times adjusted earnings, as the company continues to grow despite a GLP-1 ...

With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help ...